1-Methylpiperazine → HCID 20554355、化合物

HRID 1106027ノート

反応式

HRID 1106027 の反応式
[CH3:1][N:2]1[CH2:7][CH2:6][NH:5][CH2:4][CH2:3]1.Cl[CH2:9][C:10]([N:12]1[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=2[N:16]([CH3:23])[C:15](=[O:24])[C:14]2[CH:25]=[N:26][CH:27]=[N:28][C:13]1=2)=[O:11].C(=O)(O)[O-].[Na+]>C1C=CC=CC=1>[CH3:23][N:16]1[C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=2[N:12]([C:10](=[O:11])[CH2:9][N:5]2[CH2:6][CH2:7][N:2]([CH3:1])[CH2:3][CH2:4]2)[C:13]2[N:28]=[CH:27][N:26]=[CH:25][C:14]=2[C:15]1=[O:24]

参加物

5

反応物 3

HCID 531671-MethylpiperazineHCID 516892Sodium BicarbonateHCID 20554401HCID 20554401、化合物

生成物 1

HCID 20554355HCID 20554355、化合物

試薬・触媒・溶媒 1

HCID 241Benzene溶媒

反応条件

温度
70 °C

実験手順

2.6 g (0.0266 mol) of N-methylpiperazine are added dropwise at 50° C., in the course of 15 minutes, to a suspension of 4.0 g (0.0133 mol) of 11-chloroacetyl-6-methyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one in 30 ml of absolute benzene, and the mixture is stirred for a further 1.5 hours at 70° C. After cooling, the mixture is poured into 100 ml of saturated sodium bicarbonate solution and is extracted once with 50 ml of ethyl acetate and twice with 100 ml, each time, of chloroform. After drying, the organic phase is concentrated in vacuo, and the liquid residue is induced to crystallize by means of ether. It is purified by filtering through neutral silica gel (elution with chloroform) and evaporating the filtrate; yield: 2.7 g, m.p. 183° to 185° C.

後処理

  1. temperatureAfter cooling
  2. extractionis extracted once with 50 ml of ethyl acetate and twice with 100 ml
  3. customAfter drying
  4. concentrationthe organic phase is concentrated in vacuo
  5. customto crystallize by means of ether
  6. customIt is purified
  7. filtrationby filtering through neutral silica gel (elution with chloroform)
  8. customevaporating the filtrate

出典と根拠

ORDレコード
ord-6898a588d5d343bbb43b4a8e2a4951ab
出典データセット
uspto-grants-1982_01
特許番号
US04311700

反応ノート

読み込み中…